Weaponizing CRISPR/Cas9 for selective elimination of cells with an aberrant genome
Ontology highlight
ABSTRACT: RNA-seq profiling of HeLa GFP cells treated with a Cas9 bearing either a scramble or a GFP guide to study the activation of inflammatory pathways 3 days after Cas9 delivery
INSTRUMENT(S): NextSeq 550
ORGANISM(S): Homo sapiens
SUBMITTER:
PROVIDER: E-MTAB-14730 | biostudies-arrayexpress |
SECONDARY ACCESSION(S): ERP167413
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA